Epoch Investment Partners, Inc. Eli Lilly & CO Transaction History

Epoch Investment Partners, Inc.

$21.7 Billion
Q3 2024

A detailed history of Epoch Investment Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 244,694 shares of LLY stock, worth $189 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

244,694

Previous 277,735 11.9%

Holding current value

$189 Million

Previous $251 Million 13.79%

% of portfolio

1.0%

Previous 1.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $25.5 Million - $31.7 Million	-33,041 Reduced 11.9%	244,694 $217 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $24.6 Million - $30.8 Million	-33,912 Reduced 10.88%	277,735 $251 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $153 Million - $205 Million	-258,894 Reduced 45.38%	311,647 $242 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $128 Million - $151 Million	243,555 Added 74.48%	570,541 $333 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $24.2 Million - $33.4 Million	-55,734 Reduced 14.56%	326,986 $176 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $6.72 Million - $8.98 Million	-19,157 Reduced 4.77%	382,720 $179 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $1.05 Million - $1.23 Million	-3,376 Reduced 0.83%	401,877 $138 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $27.1 Million - $31.5 Million	84,149 Added 26.21%	405,253 $148 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $38.8 Million - $44.2 Million	-130,705 Reduced 28.93%	321,104 $104 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $2.34 Million - $2.74 Million	-8,383 Reduced 1.82%	451,809 $146 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $2.9 Million - $3.6 Million	-12,360 Reduced 2.62%	460,192 $132 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $40.3 Million - $50 Million	179,329 Added 61.16%	472,552 $131 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $1.01 Million - $1.24 Million	4,555 Added 1.58%	293,223 $67.7 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $852,196 - $1.1 Million	4,720 Added 1.66%	288,668 $66.3 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $21 Million - $27.2 Million	127,642 Added 81.66%	283,948 $53 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $5.56 Million - $7.35 Million	42,601 Added 37.47%	156,306 $26.4 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $1.24 Million - $1.44 Million	-8,505 Reduced 6.96%	113,705 $16.8 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $6.82 Million - $8.21 Million	49,997 Added 69.24%	122,210 $20.1 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $8.6 Million - $10.6 Million	72,213 New	72,213 $10 Million

Others Institutions Holding LLY

# of Institutions

4,012

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.

Account

Epoch Investment Partners, Inc. Eli Lilly & CO Transaction History